Commentary: Induction anti-angiogenesis for stage iiia (n2) nsclc is not the answer yet: Optimal induction for operable disease is a clear work in progress
1976 ◽
Vol 32
◽
pp. 109-116
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2002 ◽
Vol 29
(6 Suppl 19)
◽
pp. 38-41
◽
Keyword(s):
2010 ◽
Vol 182
(S 01)
◽
Keyword(s):